greeksoup/ stock research
Stock research / United States / MRNA / Filings

Moderna, Inc. SEC filings

Moderna filed 23 documents with the SEC in the last twelve months, the latest report being the 10-Q of 6 November 2026.

Filings in twelve months2315 of them 8-K news
Latest report10-Qfiled 6 Nov 2026
Latest filing10-Q6 Nov 2026
Last results, two-day move-4.8%results filed 31 Jul 2026
New to this? How to read this page
  1. Companies file with the SEC when something happens. 10-Q and 10-K are the quarterly and annual reports; 8-K is news that cannot wait for the next report.
  2. An 8-K says which items it covers, such as results, a change at the top or a big contract. A foreign company files a 6-K instead.
  3. The results release is usually an 8-K filed the day results come out, before the 10-Q or 10-K.
  4. Every filing links to the original on EDGAR, the SEC's own site.

Twelve months of filings

by kind

Most of the filings were other company news (10). Results came out 5 times.

Each mark is one filing on the day it was filed, in rows by kind. Hover or tap a mark for the form and what it was about.

The share price around each results release

close before to close after

Over the last 4 releases the share price moved 8.2% on average in the two days around results, the most on 12 Jan 2026 (+15.5%).

12 Jan 2026+15.5%$34.30 to $39.60
13 Feb 2026+9.5%$40.11 to $43.93
1 May 2026+3.0%$45.94 to $47.30
31 Jul 2026-4.8%$57.92 to $55.14
Daily closeResults filed

Each ring marks a results filing. The move runs from the last close before the filing to the first close after it, so it covers results released before the open or after the close. Hover the line for any day's close.

What the company told investors on 8-K

15 filings

Moderna's 15 news filings (8-K) were mostly about regulation FD disclosure (6) and results of operations (5).

  • Regulation FD disclosureMaterial shared with investors, often slides or a presentation
    6 · latest 30 Sep 2026
  • Results of operationsThe quarterly results release
    5 · latest 6 Nov 2026
  • Material agreementA large contract or deal was signed
    3 · latest 1 Sep 2026
  • Officer or director changeSomeone joined, left or changed role at the top
    2 · latest 30 Sep 2026
  • New financial obligationNew debt or a borrowing
    2 · latest 1 Sep 2026
  • Other eventsNews the company chose to file
    2 · latest 1 Sep 2026
  • Shareholder voteResults of a vote at a shareholder meeting
    2 · latest 11 May 2026
  • Unregistered sale of equityShares sold privately
    1 · latest 1 Sep 2026
  • Charter or bylaw amendment, or fiscal year changeThe company's rules or fiscal year changed
    1 · latest 11 May 2026

Each line is one kind of news, with what it means in plain words. Each square is one filing; a filing can carry more than one kind, so the squares can add up to more than the filings. The date opens the latest one on EDGAR.

How it compares

every company on the site

    The bar ranks every company on the site from the lowest on the left to the highest on the right, in three equal thirds; the small figures under it are the values where each third starts, and the black tick is the middle company. The orange dot is this company; the grey ticks are the other companies in its industry (hover or tap for names). A hatched block is companies tied at none.

    Every filing as a table

    In the last twelve months Moderna, Inc. filed 23 documents with the SEC of the kinds listed here: 15 current reports (8-K), about 6 regulation FD disclosure; 5 results of operations; 3 material agreement; 2 officer or director change; 2 new financial obligation; 3 quarterly reports (10-Q), 1 additional proxy material (DEFA14A), 1 proxy statement (DEF 14A), 1 annual report to shareholders (ARS), 1 employee share plan registration (S-8), 1 annual report (10-K). The latest, filed 6 November 2026: 10-Q, quarterly report. The reports, the proxy statement and the prospectus themselves, where filed, each with a link to open it, are on the documents page.

    FiledFormWhat it was aboutPeriod or event dateFiling
    6 November 202610-Qquarterly report30 September 2026EDGAR
    6 November 20268-KResults of operations6 November 2026EDGAR
    30 September 20268-KOfficer or director change, Regulation FD disclosure30 September 2026EDGAR
    1 September 20268-KMaterial agreement, New financial obligation, Unregistered sale of equity, Other events27 August 2026EDGAR
    31 July 202610-Qquarterly report30 June 2026EDGAR
    31 July 20268-KResults of operations31 July 2026EDGAR
    8 July 20268-KOfficer or director change, Regulation FD disclosure6 July 2026EDGAR
    11 May 20268-KCharter or bylaw amendment, or fiscal year change, Shareholder vote6 May 2026EDGAR
    1 May 202610-Qquarterly report31 March 2026EDGAR
    1 May 20268-KResults of operations1 May 2026EDGAR
    16 March 2026DEFA14Aadditional proxy materialEDGAR
    16 March 2026DEF 14Aproxy statement6 May 2026EDGAR
    16 March 2026ARSannual report to shareholders31 December 2025EDGAR
    5 March 20268-KMaterial agreement3 March 2026EDGAR
    20 February 2026S-8employee share plan registrationEDGAR
    20 February 202610-Kannual report31 December 2025EDGAR
    13 February 20268-KResults of operations13 February 2026EDGAR
    11 February 20268-KRegulation FD disclosure, Other events3 February 2026EDGAR
    12 January 20268-KResults of operations, Regulation FD disclosure12 January 2026EDGAR
    5 January 20268-KRegulation FD disclosure5 January 2026EDGAR
    24 November 20258-KMaterial agreement, New financial obligation19 November 2025EDGAR
    20 November 20258-KRegulation FD disclosure20 November 2025EDGAR
    13 November 20258-KShareholder vote12 November 2025EDGAR
    An 8-K is what a company files within four business days of a material event; the SEC numbers the events, and the words here are the SEC's own headings, shortened.
    Read moreForm 4, Form 144, 13F and Schedule 13D and 13G have their own pages. Prospectus supplements and correspondence are not listed.